BioPharma Dive 18 mar 2026 J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections
BioPharma Dive 18 mar 2026 Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
BioPharma Dive 16 mar 2026 Sarepta tests new Elevidys safeguards; Sana advances diabetes cell therapy
BioPharma Dive 13 mar 2026 With FDA go ahead, a China biotech notches a first in cell therapy testing